Local oncology practice moves to a new, expanded location to continue providing enhanced cancer care to the Naples-Goodlette community.

NAPLES, FL, June 11, 2025 – Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Goodlette clinic in Naples to 708 Goodlette-Frank Road, Suite 302, 3^rd Floor. Current or prospective patients can call (239) 231-7260 for inquiries or to schedule an appointment.

Board-certified medical oncologists Zanetta Lamar, MD,  Ferdy Santiago, MD, and Board-certified hematologist Deborah Glick, MD are now accepting patients at the new, larger Naples-Goodlette location.

The new clinic includes additional private exam rooms that provide dedicated space for patient-physician conversations, an infusion room, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics.

“Our Goodlette practice has moved to a larger suite to better serve our Naples area patients,” said Dr. Santiago. “We hold ourselves to a high standard of continuously providing exceptional, compassionate care that is central to our patient-first mindset, and is the standard in all of Florida Oncology and Hematology’s five clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our newly expanded Goodlette address in Naples.”

Florida Oncology and Hematology provides care to patients living in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Florida Oncology and Hematology provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.

The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, American Oncology Network makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.

“We are excited to welcome our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Santiago. “The relocation will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to deliver one-on-one care.”

For more information about AON, visit AONcology.com. For more information about Florida Oncology and Hematology, visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Cape Coral, Clearwater, Fort Myers, and Naples, Florida. As a community-based practice, it offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Six AON community oncology practice partners now offering radioligand therapeutics for prostate and neuroendocrine cancers

Fort Myers, Fla., May 21, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it is expanding access to cutting-edge radioligand therapies (RLT), providing more patients with targeted treatment options for certain metastatic and rare cancers. To date, more than 300 treatments have been delivered to nearly 70 patients across six AON partner practices, demonstrating both the growing demand for and success of these advanced therapies.

Radioligand therapies are now offered at the following AON practices:

• Summit Cancer Centers
• Cancer & Blood Specialists of Arizona
• Woodlands Cancer Institute
• Messino Cancer Centers
• Zangmeister Cancer Center
• Genesis Cancer and Blood Institute

These practices offer three FDA-approved radiopharmaceuticals:

• Pluvicto™ – for treatment of metastatic castration-resistant prostate cancer (mCRPC)
• Lutathera® – for adults with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
• Xofigo® (radium-223 dichloride) – for symptomatic mCRPC with bone metastases

“Radioligand therapy allows us to deliver highly targeted radiation directly to cancer cells, minimizing damage to healthy tissue and improving patient outcomes,” said Guy Messer, AON vice president of radiation and radiology services. “Our expansion of these therapies reflects AON’s continued commitment to ensuring that patients in community settings can access leading-edge treatments without having to travel far from home.”

Radioligand therapy, also know as radiopharmaceutical therapy, involves attaching a radioactive isotope to a targeting molecule that is injected into the bloodstream. This molecule binds to specific receptors on tumor cells, delivering a precise dose of radiation that damages or kills cancerous cells while sparing surrounding tissue.

Pluvicto™ is the first targeted radioligand therapy approved by the FDA to treat prostate-specific membrane antigen (PSMA)-positive mCRPC. Xofigo® is approved for men with mCRPC that has spread to the bone and who have already received androgen deprivation therapy. Lutathera® remains the only approved radiopharmaceutical for treating adult patients with GEP-NETs—a rare but increasingly diagnosed type of cancer that can develop in the pancreas, stomach, intestines or appendix.

“Continuing to increase the availability of these advanced radiopharmaceutical therapies in community oncology practices across the nation is a major step forward in personalized cancer care,” said Dr. Stephen “Fred” Divers, AON chief medical officer. “It’s part of AON’s broader mission to ensure patients nationwide have access to the latest innovations in oncology, without sacrificing the personalized care they receive close to home.”

AON expects continued growth in radioligand therapy utilization as additional sites gain the infrastructure and regulatory clearances needed to administer these specialized treatments.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Sakeer Hussain, MD, was honored for his dedication to advancing cancer policy at national and state levels during ASCO’s 2025 Advocacy Summit event.

COUNCIL BLUFFS, Iowa, May 14, 2025 –  Sakeer Hussain, MD, a Board-certified medical oncologist at Heartland Oncology and Hematology, a partner practice of the American Oncology Network (AON), has been recognized as a 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO). The distinction was announced during ASCO’s annual Advocacy Summit held in Washington, D.C. last month.

Each year, ASCO selects Advocacy Champions who have demonstrated exceptional commitment to policy advocacy in support of high-quality, equitable cancer care. Honorees actively engage lawmakers at both the state and federal levels, champion legislative priorities, and elevate the voice of the oncology community through outreach and education.

“Advocacy Champions like Dr. Hussain are driving real change in how cancer care is delivered across the country,” said Martin Palmeri, MD, MBA, chair of ASCO’s Government Relations Committee and treasurer of the Board of Directors for the Association for Clinical Oncology. “Their efforts this year have advanced critical issues such as drug shortages, securing sustainable research funding, and advocating for permanent telehealth access. These contributions will continue to benefit providers and patients alike.”

Dr. Hussain’s advocacy work spans multiple fronts. During the past year, he has met with congressional leaders in Washington, provided testimony before the Iowa House of Representatives opposing non-medical switching, and hosted his local congressman at his clinic to highlight the value of community oncology care. He has also been a consistent voice in discussions surrounding prior authorization reform and telemedicine expansion.

“I’m deeply honored to be named an ASCO Advocacy Champion,” said Dr. Hussain. “This recognition reflects my commitment to ensuring every cancer patient—regardless of geography, income, or background—has access to the timely, high-quality care they deserve. I believe advocacy is essential to closing gaps in our healthcare system, and I’m proud to contribute to that mission.”

Dr. Stephen “Fred” Divers, chief medical officer of AON, praised the recognition, noting Dr. Hussain’s advocacy impact extends far beyond his own clinic. “Dr Hussain exemplifies the spirit of community oncology and the power of physician-led advocacy,” said Dr. Divers. “His engagement with policymakers helps secure the future of local cancer care and reinforces our network’s mission to support independent practices. We’re proud of his ongoing leadership.”

For news, advocacy, and analysis on cancer policy, please visit www.asco.org/ascoaction.

For more information about AON, visit www.AONcology.com. For more information about Heartland Oncology and Hematology, visit www.heartlandoncology.com.  

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Heartland Oncology and Hematology
Heartland Oncology and Hematology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, Heartland Oncology and Hematology strives to provide the best treatment options, state-of-the-art equipment and best possible experience to patients and their families throughout the healthcare journey. Learn more at www.heartlandoncology.com.  

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

More than a dozen AON leaders to speak on panels focused on advocacy, innovation and access in independent community oncology.

FORT MYERS, Fla., April 24, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced that it will participate in 14 speaking sessions at the 2025 Community Oncology Alliance (COA) Annual Conference. The event, themed Empower & Advocate: Independent Community Oncology, will take place April 29-30 in Orlando, Florida.

“At AON, we’re committed to supporting local practices because they bring immense value to patients and communities,” said Stephen “Fred” Divers, MD, AON’s chief medical officer, medical oncologist at Genesis Cancer and Blood Institute, and conference co-chair. “The conference theme of empowerment and advocacy aligns with our mission of improving outcomes through patient-centered care, and I look forward to hearing AON thought leaders share insights with fellow community oncology colleagues.”

AON leaders will speak on a range of topics including payer contracting, value-based care, patient advocacy, clinical trials, and mental health programs. Featured speakers include:

• Stephen “Fred” Divers, MD, chief medical officer – Welcome from the Co-Chairs and Evolving Successful Hospital and Independent Community Practice Partnerships
• Alti Rahman, MHA/MBA, CSSBB, chief strategy and innovation officer – Welcome from the Co-Chairs and The Business Plan for Payer Contracting
• Sunil Babu, MD, medical oncologist, Fort Wayne Medical Oncology and Hematology – Growing Clinical Trial Infrastructure & Access in Community Oncology
• Katie Goodman, RN, vice president of clinical research – Growing Clinical Trial Infrastructure & Access in Community Oncology
• Melissa Shaw, BSN, RN, OCN, director of clinical projects, Central Georgia Cancer Care – The Value of Patient Advisory Boards
• Cassandra Perkey, PharmD, BCOP, regional clinical pharmacist – Streamlining Pharmacist-led Hyperglycemia Management in HR+ Breast Cancer
• Anne Marie Rainey, MSN, RN, CHC, CPHQ, director of value-based care – Building Effective Patient Navigation Programs
• Autumn Jones, director of radiology operations – Radiopharmaceutical Therapies: Business Mechanics & Operational Review
• Guy Messer, AS-NMT, BS-HCMGT, MBA, vice president of radiation and radiology services – Radiopharmaceutical Therapies: Business Mechanics & Operational Review
• Ruemu Birhiray, MD, medical oncologist, Hematology Oncology of Indiana – Is Mastocytosis Underdiagnosed?
• Melody Chang, RPh, MBA, BCOP, vice president of pharmacy operations – Aiming for Accuracy in Non-Small Cell Lung Cancer Treatment
• Lisa Poiry, RN, OCN, division director of quality services, Fort Wayne Medical Oncology and Hematology – State & Local Advocacy: Reaching Your Local Elected Officials
• Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC,  vice president of clinical innovation – Practices Using Data to Engage Payers
• Brian Mulherin, MD, medical oncologist, Hematology Oncology of Indiana – How to Operationalize a Mental Health Program in Your Practice
• Katie Alexander, MS, APRN-CNP, OCN, BBA, nurse practitioner and central region APP coordinator, Zangmeister Cancer Center – Leadership, Team Building and Culture in Community Oncology

“AON and COA share a mission to protect and promote independent oncology,” said Alti Rahman, AON chief strategy and innovation officer and conference co-chair. “Events like this help unify our efforts and accelerate the innovations needed to improve care across the country.”

AON provides comprehensive support services to independent oncology practices, including in-house pharmacy, lab services, revenue-diversifying programs and back-office operations. By partnering with AON, physicians can focus on delivering high-quality care in their communities without relying on hospital systems or third-party providers.

AON will also exhibit at booth 207 during the conference. Book a Discovery Meeting at COA.

For more information about AON, visit AONcology.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

FORT MYERS, Fla., April 8, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced that Anne Marie Rainey, AON’s director of value-based care, has been appointed to the Association of Cancer Care Centers’ Board of Trustees.

As director of value-based care at AON, Rainey manages internal quality, government, and value-based care initiatives. She has experience in government quality reporting as a contractor for the Centers for Medicare & Medicaid Services and the Centers for Disease Control and Prevention. After earning her Master of Science in Nursing in leadership and administration, she transitioned to community oncology, where she focuses on quality metrics analysis, program implementation, health policy, and community oncology advocacy.

“I am honored to serve on the Association of Cancer Care Centers’ Board of Trustees,” Rainey said. “I look forward to collaborating with the talented ACCC leadership team to advance oncology education and advocacy on behalf of cancer patients nationwide.”

“We are pleased to see Anne Marie appointed to ACCC’s board,” said AON CEO Todd Schonherz. “She has built an impressive career, and her dedication to AON and ACCC’s shared mission of delivering patient-first care to oncology patients nationwide makes her a perfect fit for this important role.”

Newly appointed ACCC Board of Trustees members were officially announced at ACCC’s 51^st Annual Meeting & Cancer Center Business Summit, held in March in Washington, DC. Board members will serve a two-year term, working to further ACCC’s mission of advancing the delivery of quality cancer care.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About the Association of Cancer Care Centers
The Association of Cancer Care Centers (ACCC) is the education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of more than 45,000 multidisciplinary professionals from 1,700 provider organizations nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve – so has ACCC – adapting its resources to meet the changing needs of the entire oncology care team. For more information, visit accc-cancer.org. Follow us on social media; read our blog, ACCCBuzz; tune in to our CANCER BUZZ podcast; and view our CANCER BUZZ TV channel.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com